Posts
June 23 2025
Moleculin Biotech, Inc. announced the closing of its public offering in the amount of $5,900,000. EG&S acted as counsel to the placement agent.
June 20 2025
Axiom Intelligence Acquisition Corp 1 announced the closing of its initial public offering in the amount of $200,000,000. EGS acted as counsel to Axiom Intelligence Acquisition Corp 1.
June 20 2025
Reliance Global Group, Inc. announced the closing of its private placement offering in the amount of $6,750,000. EG&S acted as counsel to the placement agent.
June 20 2025
Aptevo Therapeutics Inc. announced the closing of its registered direct offering in the amount of $8,000,000. EG&S acted as counsel to the placement agent.
June 19 2025
Pioneer Acquisition I Corp announced the closing of its initial public offering in the amount of $253,000,000. EGS acted as counsel to the underwriter.
June 18 2025
Quince Therapeutics, Inc. announced the closing of its private placement offering in the amount of $22,000,000. EG&S acted as counsel to the placement agent.
June 18 2025
Robin Energy Ltd. announced the closing of its registered direct offering in the amount of $4,500,000. EG&S acted as counsel to the placement agent.
June 18 2025
Processa Pharmaceuticals, Inc. announced the closing of its public offering in the amount of $7,000,000. EG&S acted as counsel to the placement agent.